Amundi Roche Hldg LTD Spons Adr Transaction History

Amundi

$264 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$39.15 - $43.25 $39 - $43	-1 Reduced 0.03%	3,959 $154,000
Q3 2022 Nov 14, 2022	SELL	$38.69 - $42.93 $851 - $944	-22 Reduced 0.55%	3,960 $161,000
Q2 2022 Aug 15, 2022	SELL	$38.21 - $53.44 $1,528 - $2,137	-40 Reduced 0.99%	3,982 $166,000
Q1 2022 May 16, 2022	SELL	$45.31 - $51.78 $18,350 - $20,970	-405 Reduced 9.15%	4,022 $199,000
Q3 2021 Nov 15, 2021	SELL	$44.81 - $50.76 $7,796 - $8,832	-174 Reduced 3.78%	4,427 $201,000
Q2 2021 Aug 16, 2021	BUY	$40.63 - $47.81 $186,938 - $219,973	4,601 New	4,601 $216,000

Others Institutions Holding RHHBY

# of Institutions

76

Shares Held

8.29M

Call Options Held

0

Put Options Held

0

Aristotle Capital Management, LLC Los Angeles, CA

2.39M
Shares

$93.8 Million
0.18% of portfolio
Saratoga Research & Investment Management

2.33M
Shares

$91.3 Million
4.07% of portfolio
Pacer Advisors, Inc. Malvern, PA

1.12M
Shares

$44.1 Million
0.1% of portfolio
Boston Common Asset Management, LLC Boston, MA

296K
Shares

$11.6 Million
0.61% of portfolio
Old National Bancorp

255K
Shares

$10 Million
0.21% of portfolio

About ROCHE HLDG LTD SPONS ADR

Ticker RHHBY
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 6,404,630,016
Market Cap $251B

More about RHHBY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.